Related by context. All words. (Click for frequent words.) 72 ALDH2 deficiency 71 Convivia 69 Iluvien ® 68 Iluvien TM 67 intranasal formulation 67 Aeroquin 67 RhuDex ® 66 acetonide FA 66 aldehyde dehydrogenase ALDH2 deficiency 66 oral prodrug 66 targeted radiotherapeutic 64 intravenous AAT 64 treat chronic sinusitis 64 Phase #b/#a clinical 64 Dyloject TM 64 delivers fluocinolone acetonide FA 64 Retacrit 64 EVIZON ™ 64 Factor VIIa 63 MOVIPREP R 63 Phase Ib clinical trials 63 PrevOnco ™ 63 histone deacetylase HDAC inhibitor 63 Zemiva TM 63 mertansine 63 liposomal formulation 63 DURIN TM 63 Alferon N 63 reslizumab 63 topical ophthalmic 63 Mpex 63 NeuroSTAT ® 63 miconazole Lauriad ® 63 ATL# [002] 63 MAGE A3 ASCI 63 Aerosurf 63 Kamada AAT 62 TOCOSOL 62 topically administered 62 Lixivaptan 62 Initiates Clinical 62 lumiliximab 62 GW# [003] 62 Auxilium transmucosal film 62 Valtropin 62 Phase IIb clinical trials 62 candidate TNFerade biologic 62 vapreotide acetate 62 nephropathic cystinosis 62 acyclovir Lauriad R 62 receptor tyrosine kinase inhibitor 62 PDE4 inhibitor 62 Initiates Enrollment 62 Familial Adenomatous Polyposis FAP 62 immunotherapeutic vaccine 62 successfully commercialize Iluvien 62 PrevOnco 62 TransMID 62 RhuDex R 62 CRD5 62 BrachySil TM 62 vinorelbine tartrate 62 Activity Assay 62 iobenguane 62 therapeutic monoclonal antibody 62 AAG geldanamycin analog 62 OncoGel 62 Junovan TM 62 Dacogen decitabine 62 ALTROPANE R 62 targeted tyrosine kinase 62 Myocet 62 inhaled AAT 62 ARIKACE ™ 62 Cloretazine 62 OHR/AVR# 62 CEQ# 62 Cardio Vascu Grow 62 herpetic keratitis 62 Qutenza TM 62 OvaRex R 62 IMA# 61 Spiegelmer ® 61 Squalamine 61 novel histone deacetylase 61 HQK 61 intravenous acetaminophen 61 Bioral 61 Marqibo TM 61 volociximab 61 Initiate Clinical Trial 61 Maribavir 61 parenterally administered 61 Anavex #-# 61 XL# XL# 61 Angiocept 61 XP# XP# 61 RTP #i 61 Mepact 61 systemic immunosuppressive drugs 61 BEMA Granisetron 61 LEP ETU 61 Anidulafungin 61 FluCide 61 PORxin TM 61 Pafuramidine 61 novel prodrug 61 hypoxia activated prodrug 61 UPLYSO 61 ocular formulation 61 AQ4N 61 non nucleoside 61 Dual Opioid 61 Onconase 61 molecular imaging radiopharmaceutical 61 Cloretazine ® 61 Nektar proprietary 61 Chimigen 61 Trofex 61 G#DT 61 ATL/TV# 61 Silodosin 61 ILUVIEN ® 61 oral salmon calcitonin 61 AzaSite Plus 61 CG# [003] 61 RH1 61 afamelanotide 61 LHRH antagonist 61 Phase Ib clinical 61 PNP inhibitor 61 ciprofloxacin hydrochloride 61 Liprotamase 61 Dual Opioid TM 60 non alcoholic steatohepatitis 60 IAP inhibitor 60 aerosolized AAT 60 Safinamide 60 Pradefovir 60 nucleoside analog 60 SURFAXIN r 60 Noxafil 60 ALN TTR 60 candidate REP# 60 lomitapide 60 Urocidin 60 Zenapax 60 IV Busulfex 60 generation purine nucleoside 60 humanized monoclonal 60 YONDELIS 60 JAK2 inhibitor 60 Ganciclovir 60 selective antagonist 60 selective adenosine 60 Initiates Phase II 60 levoleucovorin 60 PEGylated interferon 60 5 HT3 antagonist 60 triphendiol 60 Xanafide 60 selective androgen receptor modulator 60 novel emulsion formulation 60 SinuNase ™ 60 oncolytic virus therapies 60 diarrhea predominant irritable 60 ULTRASE 60 HuLuc# 60 topical formulation 60 TBC# 60 tafamidis 60 Generx ™ 60 subcutaneous formulation 60 miconazole Lauriad R 60 NP2 60 SEPET TM 60 Luteinizing Hormone Releasing Hormone 60 IGF 1R inhibitor 60 NeuVax 60 Protexia 60 orally inhaled 60 Soliris eculizumab 60 amifampridine phosphate 60 THR beta agonist 60 Zemiva ™ 60 dasatinib Sprycel ® 60 BCG refractory carcinoma 60 SNT MC# 60 personalized dendritic 60 nasally delivered 60 Pancreate 60 rusalatide acetate 60 R#/MEM # 60 Zybrestat 60 Cleviprex TM clevidipine 60 anticancer compound 60 rxRNA 60 tiapamil 60 novel oral anticoagulant 60 Alzhemed TM 60 GLP toxicology studies 60 BrachySil ™ 60 beta 1a 60 CINTREDEKIN BESUDOTOX 60 HepeX B 60 ALN TTR# 60 Proquin XR 60 anti infective treatments 60 phase IIb clinical 60 Aviptadil 60 ruxolitinib 60 gets USFDA nod 60 Poly ICLC 60 Prednisporin 60 Emezine 60 Zenvia ™ 60 LymphoStat B TM 60 topical antifungal 60 Fodosine 60 radiation sensitizer 60 OMNARIS HFA 60 Archexin 60 Loxapine 60 synthetic retinoid 60 inhaled liposomal ciprofloxacin 60 CCR5 inhibitor 60 Tarceva TM 60 CCR5 antagonist 59 Anturol ® 59 Synerx Pharma 59 polysaccharide polymer 59 rilonacept 59 transmucosal delivery system 59 TG# [003] 59 Insegia 59 VitiGam TM 59 Dalbavancin 59 MyVax ® 59 sargramostim 59 acyclovir Lauriad ® 59 Octreolin 59 DermaVir Patch 59 Octreotide 59 ATL# [001] 59 selective immunoproteasome inhibitor 59 Relivar 59 poly ethylene glycol PEG 59 Davanat 59 Opterone R 59 orally dosed 59 Hsp# Inhibitor 59 VitiGam 59 Polymer Microspheres 59 Oasmia 59 HepDirect prodrug 59 LibiGel ® 59 IL# PE#QQR 59 Annamycin 59 Alvesco R 59 sublingual tablets 59 PREOS R 59 Evoltra ® 59 Solazed TM 59 topical formulations 59 AKT inhibitor 59 proprietary intranasal insulin 59 personalized immunotherapy 59 EVIZON TM 59 histone deacetylase inhibitor 59 AzaSite Xtra 59 Plenaxis TM 59 phase IIa clinical 59 Leukine ® 59 Veregen TM 59 Oral Spray 59 candidate deforolimus 59 recombinant FVIII 59 ONTAK 59 lucinactant 59 Intercell vaccine 59 investigational humanized monoclonal antibody 59 TH# [003] 59 JAK inhibitor 59 denileukin diftitox 59 injectable formulation 59 Kuvan R 59 plasmid encoding 59 Meritage Pharma 59 mitogen activated ERK kinase 59 TELINTRA 59 Troxatyl TM 59 ELIQUIS 59 forodesine hydrochloride 59 selective kinase inhibitor 59 JAK2 Inhibitor 59 Onalta ™ 59 benign prostatic hypertrophy BPH 59 Prodarsan R 59 paclitaxel poliglumex 59 sterile lidocaine patch 59 Submits IND 59 BCR ABL inhibitors 59 VIAject R 59 HuMax 59 Aurora kinase inhibitor 59 mesylate 59 Vidaza azacitidine 59 buccal spray 59 plasmid DNA pDNA 59 Firazyr 59 relapsed leukemia 59 intranasal insulin product 59 Phase 1b clinical 59 ATPace TM 59 Aflibercept 59 Phase Ib study 59 octreotide implant 59 Zingo TM 59 TRANSDUR Bupivacaine 59 lexidronam injection 59 Chimigen TM 59 HCV protease inhibitors 59 Troxatyl 59 #D#C# 59 PSN# [001] 59 Ceflatonin 59 FVIIa 59 Granulocyte Colony Stimulating Factor 59 Triapine 59 pafuramidine maleate 59 Preclinical studies suggest 59 Montigen 59 HuCAL antibodies 59 aerosol formulation 59 vascular disrupting agent 59 tezampanel NGX# 59 DepoDur 59 Somatuline R Depot 59 Neo Urinary Conduit 59 TLK# 59 orally administered inhibitor 59 Pimavanserin 59 XL# anticancer compounds 59 HuMax TAC 59 CYT# potent vascular disrupting 59 non nucleoside inhibitor 59 cystinosis patients 59 EOquin 59 Civacir 59 GVAX ® 59 metaglidasen 59 KL4 Surfactant 59 PEP# [003] 59 Degarelix 59 ONCONASE R 59 Multiple Ascending Dose 59 midstage trials 59 inhalation powder 59 Solazed 59 Personalized Immunotherapy 59 Zemplar Capsules 59 factor VIIa 59 methylnaltrexone bromide 59 Granted Orphan Drug 59 Occlusin TM 59 diclofenac sodium 59 BIM #A# 59 SUTENT ® 59 Meets Primary Endpoint 59 cannabinor 59 Lauriad 59 Orally administered 59 antiangiogenic agent 59 Behcet uveitis 59 Spiegelmer 58 Liposomal 58 topically applied SEPA 58 VersaFilm 58 fosbretabulin 58 Solzira ™ 58 Intermezzo ® zolpidem tartrate 58 Ozarelix 58 eligen 58 Vicinium TM 58 rhITF 58 Teysuno 58 Captisol Enabled 58 Kuvan sapropterin dihydrochloride 58 GTC recombinant human 58 Onalta TM 58 Fibrillex TM 58 mecasermin 58 ONCASPAR 58 PEGylated Fab fragment 58 XmAb 58 myelodysplastic myeloproliferative diseases 58 Panzem ® 58 Trobalt 58 alvespimycin 58 Mipomersen 58 IV acetaminophen 58 Omigard 58 refractory chronic lymphocytic 58 HERCEPTIN 58 SCIB1 58 Targeted Chemotherapy 58 topical ocular 58 Urocidin TM 58 Prodarsan ® 58 ChimeriVax JE 58 oral methylnaltrexone 58 delivers sumatriptan 58 forodesine 58 targeted antifolate 58 Oxytrex TM 58 selective orally bioavailable 58 JZP 58 histamine dihydrochloride 58 Peginterferon alfa 2b 58 Zorbtive TM 58 Maxy G# 58 AERx ® 58 Successfully Completes Phase 58 topical NSAID 58 initiated Phase Ib 58 adrenergic regulation 58 cathepsin K inhibitor 58 Pazopanib 58 Hexvix ® 58 TransVax tm 58 Receives Orphan Drug Designation 58 Polyphenon ® E 58 octreotide acetate 58 tramiprosate 58 NB S# strontium malonate 58 SPL# Gel vaginal microbicide 58 StemEx 58 Cutanea 58 PSMA ADC 58 hyperimmune products 58 Taclonex R 58 RenaZorb 58 Anturol TM 58 Cintredekin Besudotox 58 LE SN# 58 Alfacell proprietary ribonuclease 58 Solorel ® 58 Phase IIa Clinical Trial 58 nucleotide analog 58 Excellagen 58 rhFVIIa 58 APEX PD 58 omacetaxine mepesuccinate 58 TRO# 58 Aplidin 58 human C1 inhibitor 58 BCR ABL inhibitor 58 Vantas 58 TRISENOX ® 58 docetaxel Taxotere R 58 hoFH 58 Generx TM 58 Saizen R 58 radiotherapeutic 58 PI3K/Akt pathway inhibitor 58 INS# [001] 58 Bendamustine 58 Collategene 58 torezolid phosphate 58 2 methoxyestradiol 58 novel immunotherapeutic 58 DepoVax TM 58 Prednisporin TM 58 CYT# QbG# 58 Chemophase 58 AEG# 58 cancer immunotherapies 58 drug GLPG# 58 BEMA TM Fentanyl 58 molecular diagnostic assay 58 Panzem R 58 biodegradable implant 58 NAGS deficiency 58 patented Bioral 58 BNC# 58 investigational antiplatelet agent 58 Files IND 58 molecular chaperone regulation 58 Presents Preclinical 58 highly selective inhibitor 58 dSLIM 58 potently inhibit 58 peripherally acting 58 oral formulation 58 DOS# 58 capsules USP 58 DuraSite ® 58 anti CD3 monoclonal 58 Interferon alpha 58 CardioPass TM 58 Panzem NCD 58 Hedgehog Pathway Inhibitor 58 etanercept Enbrel 58 initiate Phase IIa 58 Levoleucovorin 58 Raptiva R 58 PANVAC VF 58 Virulizin 58 drug ISA# 58 anti botulism antibody 58 autoimmune uveitis 58 calcitonin gene related 58 Panzem R NCD 58 small molecule tyrosine 58 IAP inhibitors 58 Nanobody 58 selective receptor agonist 58 selective estrogen receptor modulator 58 TLR9 agonist 58 Duromist ™ 58 ALN PCS 58 Guanilib 58 Azedra 58 NS5A inhibitor 58 immunomodulatory therapy 58 prokinetic agent 58 CB2 selective receptor agonist 58 Kosan dependence 58 Enkephalin 58 Removab 58 Prodrug 58 Rescula 58 TAXUS Element Paclitaxel Eluting 58 mild vasodilator 58 Irinotecan 58 vinca alkaloid 58 Inhalation Powder 58 Triapine R 58 Intravail R 58 injectable collagenase 58 CIP TRAMADOL ER 58 orally bioavailable 58 thalidomide Thalomid 58 HepaGam B 58 Phase #b/#a 58 CCX# 58 Allovectin 7 58 Gamunex C 58 Therapeutic Vaccine 58 KNS # 58 InterfeRx 58 systemic RNAi 58 Zirgan 58 siRNA therapeutic 58 lintuzumab SGN 58 ACUROX 58 erlotinib Tarceva ® 58 clonidine hydrochloride 58 docetaxel Taxotere ® 58 metastatic carcinoid 58 Unit Dose Budesonide 58 bioFILM PA TM 58 Bezielle 58 CytoSorb TM 58 Fentanyl TAIFUN R 58 ISTODAX 58 MyVax R 58 ART# 58 Pruvel 58 AZILECT ® 58 Vitrasert R 58 Entereg TM 57 MKC# MKC# PP 57 OXIGON TM 57 Ceplene TM 57 recombinant interferon 57 SynCon 57 Nipent R 57 Gelclair 57 Medidur TM FA 57 Bellicum 57 DP VPA 57 VivaGel ™ 57 acadesine 57 Allovectin 7 R 57 SIR Spheres 57 GeneICE 57 ND# [002] 57 Telatinib 57 Vascular Wrap TM 57 Sandimmune 57 sumatriptan DosePro 57 systemic RNAi therapeutic 57 Anticalin R 57 Pyridorin 57 CCR9 antagonist 57 Epratuzumab 57 Altastaph 57 orally disintegrating 57 hereditary deficiency 57 corticosteroid dexamethasone 57 Pharmacokinetics PK 57 anti angiogenic agent 57 Surfaxin LS 57 Argatroban 57 humanised monoclonal antibody 57 Anticalins R 57 Belerofon 57 cleavable linker 57 topical alprostadil 57 ENMD # 57 Mycophenolate Mofetil 57 Crofelemer budesonide foam 57 Aganocide 57 Gliadel Wafer 57 XOMA 3AB 57 Panzem 57 uremic pruritus 57 Cerashield ™ 57 Cancidas 57 Raptiva ® 57 somatostatin analogue 57 Completes Patient Enrollment 57 long acting muscarinic 57 HSP# inhibitor 57 dirucotide MBP# 57 Navelbine ® 57 gastrointestinal stromal tumors GIST 57 lipopeptide 57 transmucosal film 57 Lenocta TM 57 EP #R 57 phase Ib 57 INT# [002] 57 novel therapeutic antibodies 57 AdhTAP 57 Keppra XR 57 FOLOTYN ® 57 oral candidiasis 57 multicenter Phase II 57 PDX pralatrexate 57 Sanvar R 57 RECOTHROM R 57 Potelligent Technology 57 STEDESA 57 Nivestim 57 Phase 1a clinical 57 ospemifene 57 telaprevir VX 57 opioid bowel dysfunction 57 RenaZorb TM 57 ATD gel 57 hyperphenylalaninemia HPA due 57 CryoCor Cardiac Cryoablation System 57 dasatinib Sprycel 57 POTELLIGENT ® 57 MyVax personalized immunotherapy 57 Optiquel ™ 57 GLP1 INT TM 57 HEPLISAV TM 57 Mitoxantrone 57 PPAR gamma agonists 57 NS#/#A protease 57 vaginally administered lidocaine 57 ProMune 57 PHX# 57 Romidepsin 57 resolvin 57 luteinizing hormone releasing 57 zolpidem tartrate sublingual tablet 57 eFlow R 57 Ciclesonide 57 liposomal delivery 57 dihydrochloride 57 Entocort 57 Kahalalide F 57 Zelrix 57 Homspera TM 57 theranostic 57 taxane derivative 57 MAXY G# 57 HCV RNA polymerase 57 vidofludimus 57 Onco TCS 57 HGS# 57 Dabigatran etexilate 57 SGLT2 inhibitor 57 ara C 57 Linjeta TM 57 non nucleoside HCV 57 topical anti infective 57 faropenem 57 PSN# [002] 57 MVA HPV IL2 57 CDP# 57 injectable formulations 57 oropharyngeal candidiasis OPC 57 developing TB4 57 BAL# [002] 57 immatics 57 polycythemia vera essential thrombocythemia 57 HuMax CD4 57 EOquin TM 57 ORADUR TM 57 DB# [003] 57 romidepsin novel 57 DXL# 57 neuraminidase inhibitor 57 Melphalan 57 proprietary intravenous formulation 57 Bioral Amphotericin B. 57 sodium stibogluconate 57 Traficet EN 57 Phase IIA 57 Perflubutane Polymer Microspheres 57 MKC# MT 57 Glassia 57 tumor vascular disrupting 57 AGHD 57 Japanese Encephalitis vaccine 57 molecular imaging radiopharmaceuticals 57 cGMP manufacture 57 Onrigin 57 OMP #M# 57 TNF Tumor Necrosis Factor 57 Cellegesic 57 Harry Palmin President 57 secondary hyperparathyroidism 57 PDL# 57 Actimmune ® 57 SILENOR 57 rasagiline tablets 57 Gleevec resistant 57 Aganocide ® 57 novel peptides 57 Vertex hepatitis C 57 peritumoral brain edema 57 GRNVAC1 57 Arzerra ofatumumab 57 huC# DM4 57 CRMD# 57 dermal patch 57 investigational hepatitis C 57 GATTEX TM 57 VEGF inhibitor 57 MYLOTARG 57 StaphVAX R 57 Prosaptide 57 balsalazide tablet 57 Hemopurifier ® 57 adalimumab Humira 57 Lubiprostone 57 PHASE III 57 Vidaza R 57 Vascular Disrupting Agent 57 tumors GIST 57 Etravirine 57 Bioaccelerate compounds under 57 Litx 57 pregabalin Lyrica 57 investigational integrase inhibitor 57 LEVADEX ™ 57 Tectin 57 Filgrastim 57 KIACTA ™ 57 delivery polymer matrix 57 RELOVAIR ™ 57 pegylated recombinant 57 SYCREST 57 SPRIX ® 57 macrolide antibiotic 57 VALSTAR TM 57 Plasmin 57 tramiprosate Alzhemed TM 57 PF # [002] 57 GEM OS2 57 Kepivance 57 CTAP# Capsules 57 REGEN trial 57 ZFP Therapeutics 57 oral antiviral 57 either acutely decompensated 57 Amplimexon 57 cysteamine 57 pharmacodynamic properties 57 proprietary DuraSite ® 57 microtubule inhibitor 57 KSP inhibitor 57 renin inhibitor 57 oxybutynin gel 57 Novolimus 57 Darusentan 57 Voraxaze 57 Cloretazine R 57 Orphan Drug designations 57 unoprostone isopropyl 57 stated Michelle Berrey 57 Apaziquone 57 KRN# 57 PEGylated anti 57 EpiCeram 57 selective A2A adenosine receptor 57 Velcade bortezomib 57 IMPACS R 57 Soliris TM eculizumab 57 Inhalation Solution 57 Perforomist ™ Inhalation Solution 57 Xyfid TM 57 Glatiramer acetate 57 crofelemer 57 Onalta 56 Fx #A 56 tolperisone 56 visilizumab 56 Scancell 56 CD# monoclonal antibody 56 DUROS 56 CVac 56 HDAC Inhibitor 56 ORE# 56 incyclinide 56 Alkaline Phosphatase 56 proprietary transdermal patch 56 JVRS 56 BioGard 56 MelaFind R 56 5 HT2A inverse 56 ALVESCO ® 56 tolevamer 56 Daclizumab 56 Axenohl 56 Pentad TM 56 next generation URAT1 56 Memryte 56 MEK inhibitor 56 transmucosal delivery 56 PROfusion 56 metastatic malignant 56 melphalan prednisone 56 kidney urologic 56 Files Investigational 56 BRILINTA 56 KL4 surfactant 56 small molecule chemotherapeutic 56 LPLD 56 SCENESSE ® 56 lorvotuzumab mertansine 56 Aztreonam 56 pradefovir 56 Ecallantide 56 muscarinic receptor agonist 56 hypereosinophilic syndrome 56 MTP inhibitor 56 constipation OIC 56 Xerecept 56 Medidur 56 AVP #D# 56 Omapro 56 Elan NanoCrystal 56 valent conjugate vaccine 56 Gleevec imatinib mesylate 56 essential thrombocythemia ET 56 XYOTAX TM 56 radiolabelled 56 Initiate Phase 56 Deferiprone 56 Albugon 56 IMiDs R 56 Novasome R 56 VIR# 56 Alinia 56 carcinoid syndrome 56 confirmatory Phase III 56 novel L DOS# 56 Vaprisol 56 Specifid 56 #L Sterilizer 56 trastuzumab DM1 T DM1 56 torezolid 56 alemtuzumab Campath 56 itraconazole Sporanox 56 Diamyd R 56 virus HCV protease inhibitor 56 Refractory Angina 56 Cinryze ™ 56 OMNARIS AQ 56 SARMs 56 trabectedin 56 OMAPRO ™ 56 Orapred ODT 56 Replacement Therapy 56 hyaluronidase enzyme 56 adenosine A2A 56 Selective Electrochemical Tumor Ablation 56 Capsulution 56 Phenoptin 56 HCV polymerase 56 recombinant factor VIIa 56 Combunox 56 sorafenib tablets 56 topical lotion 56 SYN# 56 IRX 2 56 ALN HPN 56 chronic idiopathic thrombocytopenic purpura 56 Hedgehog antagonist 56 outlicensed 56 NurOwn 56 sublingual formulation 56 Somatuline R Autogel R 56 PLK1 SNALP 56 gemcitabine Gemzar ® 56 Cloretazine R VNP#M 56 Shigamabs ® 56 Cannabinor 56 BLA filing 56 induced macular edema 56 hepatitis B immune globulin 56 Vandetanib 56 photodisinfection 56 rhLF 56 LB# [003] 56 advanced metastatic renal 56 refractory APL 56 Anthim 56 OncoVEX 56 IONSYS TM 56 Bicifadine 56 Tyzeka Sebivo 56 Sym# 56 PROMACTA 56 CCX# B 56 Curaxin 56 palifermin 56 KAPVAY ™ 56 aerosolized surfactant 56 vinflunine 56 RAV# 56 ADVANCE PD 56 Solazed ™ 56 tanespimycin 56 AN# novel 56 SURFAXIN 56 MT#/MEDI-# 56 Kinase Inhibitor 56 novel VDA molecule 56 DPX Survivac 56 SGLT2 inhibitors 56 Lamictal ODT 56 MGd 56 Aryplase 56 Cytarabine 56 Nitazoxanide 56 PD LID 56 Phase 2b clinical trials 56 Blinatumomab 56 BLP# Liposome Vaccine 56 Phase #b/#a trial 56 hormone LHRH antagonist 56 cariprazine 56 AFREZZA TM 56 Loramyc TM 56 HIV integrase inhibitor 56 Frova ® 56 histone deacetylase HDAC inhibitors 56 somatostatin analog 56 DR Cysteamine 56 Tezampanel 56 highly selective adenosine 56 thetreatment 56 Chipscreen 56 phase IIb study 56 painful diabetic neuropathy 56 Fentanyl Taifun 56 subcutaneous immunoglobulin 56 GnRH antagonist 56 Cinquil 56 alefacept 56 Ketotransdel 56 Drug Candidate 56 multi kinase inhibitor 56 favorable pharmacokinetic profile 56 candidate AQ4N 56 Phase 2a clinical trials 56 Ofloxacin 56 JP-#/fipamezole 56 trastuzumab Herceptin R 56 darinaparsin ZIO 56 anti CD3 56 LUCASSIN 56 candidates Azedra TM 56 potent antiproliferative 56 Ceflatonin R 56 chemotherapy induced neutropenia 56 demonstrated antitumor activity 56 tuberous sclerosis TS 56 Indomethacin 56 OLpur TM H2H 56 oral nucleoside analogue